103 related articles for article (PubMed ID: 18623169)
1. Subtype selective kainic acid receptor agonists: discovery and approaches to rational design.
Bunch L; Krogsgaard-Larsen P
Med Res Rev; 2009 Jan; 29(1):3-28. PubMed ID: 18623169
[TBL] [Abstract][Full Text] [Related]
2. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
[TBL] [Abstract][Full Text] [Related]
3. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine.
Frydenvang K; Lash LL; Naur P; Postila PA; Pickering DS; Smith CM; Gajhede M; Sasaki M; Sakai R; Pentikaïnen OT; Swanson GT; Kastrup JS
J Biol Chem; 2009 May; 284(21):14219-29. PubMed ID: 19297335
[TBL] [Abstract][Full Text] [Related]
4. Divergent pharmacological activity of novel marine-derived excitatory amino acids on glutamate receptors.
Sanders JM; Ito K; Settimo L; Pentikäinen OT; Shoji M; Sasaki M; Johnson MS; Sakai R; Swanson GT
J Pharmacol Exp Ther; 2005 Sep; 314(3):1068-78. PubMed ID: 15914675
[TBL] [Abstract][Full Text] [Related]
5. Design, total synthesis, and biological evaluation of neodysiherbaine A derivative as potential probes.
Sasaki M; Tsubone K; Shoji M; Oikawa M; Shimamoto K; Sakai R
Bioorg Med Chem Lett; 2006 Nov; 16(22):5784-7. PubMed ID: 16949819
[TBL] [Abstract][Full Text] [Related]
6. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
[TBL] [Abstract][Full Text] [Related]
7. Kainate receptor agonists and antagonists mediate tolerance to kainic acid and reduce high-affinity GTPase activity in young, but not aged, rat hippocampus.
Hesp BR; Wrightson T; Mullaney I; Kerr DS
J Neurochem; 2004 Jul; 90(1):70-9. PubMed ID: 15198668
[TBL] [Abstract][Full Text] [Related]
8. Ligands for ionotropic glutamate receptors.
Swanson GT; Sakai R
Prog Mol Subcell Biol; 2009; 46():123-57. PubMed ID: 19184587
[TBL] [Abstract][Full Text] [Related]
9. Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotropic glutamate receptor subtypes 5, 6, and 7.
Sagot E; Pickering DS; Pu X; Umberti M; Stensbøl TB; Nielsen B; Chapelet M; Bolte J; Gefflaut T; Bunch L
J Med Chem; 2008 Jul; 51(14):4093-103. PubMed ID: 18578478
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of (4R)-alkyl glutamate analogues at the ionotropic glutamate receptors--focus on subtypes iGlu(5-7).
Bunch L; Gefflaut T; Alaux S; Sagot E; Nielsen B; Pickering DS
Eur J Pharmacol; 2009 May; 609(1-3):1-4. PubMed ID: 19285062
[TBL] [Abstract][Full Text] [Related]
11. Exploring kainate receptor pharmacology using molecular dynamics simulations.
Postila PA; Swanson GT; Pentikäinen OT
Neuropharmacology; 2010 Feb; 58(2):515-27. PubMed ID: 19737573
[TBL] [Abstract][Full Text] [Related]
12. Partial agonism and antagonism of the ionotropic glutamate receptor iGLuR5: structures of the ligand-binding core in complex with domoic acid and 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid.
Hald H; Naur P; Pickering DS; Sprogøe D; Madsen U; Timmermann DB; Ahring PK; Liljefors T; Schousboe A; Egebjerg J; Gajhede M; Kastrup JS
J Biol Chem; 2007 Aug; 282(35):25726-36. PubMed ID: 17581823
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.
Lash-Van Wyhe LL; Postila PA; Tsubone K; Sasaki M; Pentikäinen OT; Sakai R; Swanson GT
Neuropharmacology; 2010 Mar; 58(3):640-9. PubMed ID: 19962997
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of a scaffold for iGluR ligands based on the structure of (-)-dysiherbaine.
Cohen JL; Limon A; Miledi R; Chamberlin AR
Bioorg Med Chem Lett; 2006 Apr; 16(8):2189-94. PubMed ID: 16455241
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological effects of kainic acid on vasopressin-enhanced green fluorescent protein and oxytocin-monomeric red fluorescent protein 1 neurones isolated from the supraoptic nucleus in transgenic rats.
Ohkubo J; Ohbuchi T; Yoshimura M; Maruyama T; Ishikura T; Matsuura T; Suzuki H; Ueta Y
J Neuroendocrinol; 2014 Jan; 26(1):43-51. PubMed ID: 24341559
[TBL] [Abstract][Full Text] [Related]
16. Determination of binding site residues responsible for the subunit selectivity of novel marine-derived compounds on kainate receptors.
Sanders JM; Pentikäinen OT; Settimo L; Pentikäinen U; Shoji M; Sasaki M; Sakai R; Johnson MS; Swanson GT
Mol Pharmacol; 2006 Jun; 69(6):1849-60. PubMed ID: 16537793
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis and biological evaluation of neodysiherbaine A and analogues.
Shoji M; Akiyama N; Tsubone K; Lash LL; Sanders JM; Swanson GT; Sakai R; Shimamoto K; Oikawa M; Sasaki M
J Org Chem; 2006 Jul; 71(14):5208-20. PubMed ID: 16808508
[TBL] [Abstract][Full Text] [Related]
18. The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.
Clausen RP; Naur P; Kristensen AS; Greenwood JR; Strange M; Bräuner-Osborne H; Jensen AA; Nielsen AS; Geneser U; Ringgaard LM; Nielsen B; Pickering DS; Brehm L; Gajhede M; Krogsgaard-Larsen P; Kastrup JS
J Med Chem; 2009 Aug; 52(15):4911-22. PubMed ID: 19588945
[TBL] [Abstract][Full Text] [Related]
19. Rational design and enantioselective synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-dicarboxylic acid - a novel inhibitor at human glutamate transporter subtypes 1, 2, and 3.
Bunch L; Nielsen B; Jensen AA; Bräuner-Osborne H
J Med Chem; 2006 Jan; 49(1):172-8. PubMed ID: 16392801
[TBL] [Abstract][Full Text] [Related]
20. Enantioselective Synthesis of (-)-Dysiherbaine.
Do H; Kang CW; Cho JH; Gilbertson SR
Org Lett; 2015 Aug; 17(16):3972-4. PubMed ID: 26258884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
